Split History
ETFs Holding CYTR »    CYTR Historical Stock Prices »
Video: What is a Stock Split?


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
CytRx is a biopharmaceutical research and development company focusing on oncology. Co. focuses on the discovery, research and clinical development of anti-cancer drug candidates that utilize LADR™ (Linker Activated Drug Release) technology platform to develop the accumulation and release of cytotoxic anti-cancer agents at the tumor. Co. has worked to develop and focused on the research and clinical development of aldoxorubicin, its modified version of the chemotherapeutic agent, doxorubicin. Aldoxorubicin is a conjugate of the commonly prescribed chemotherapeutic agent doxorubicin that binds to circulating albumin in the bloodstream and to concentrate the drug at the site of tumors. According to our CYTR split history records, CytRx has had 4 splits.
CYTR split history picture
CytRx (CYTR) has 4 splits in our CYTR split history database. The first split for CYTR took place on February 06, 1996. This was a 1 for 4 reverse split, meaning for each 4 shares of CYTR owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 250 share position following the split. CYTR's second split took place on May 16, 2012. This was a 1 for 7 reverse split, meaning for each 7 shares of CYTR owned pre-split, the shareholder now owned 1 share. For example, a 250 share position pre-split, became a 35.7142857142857 share position following the split. CYTR's third split took place on March 07, 2008. This was a 10000 for 8616 split, meaning for each 8616 shares of CYTR owned pre-split, the shareholder now owned 10000 shares. For example, a 35.7142857142857 share position pre-split, became a 41.4511208383075 share position following the split. CYTR's 4th split took place on November 01, 2017. This was a 1 for 6 reverse split, meaning for each 6 shares of CYTR owned pre-split, the shareholder now owned 1 share. For example, a 41.4511208383075 share position pre-split, became a 6.90852013971791 share position following the split.

When a company such as CytRx splits its shares, the market capitalization before and after the split takes place remains stable, meaning the shareholder now owns more shares but each are valued at a lower price per share. Often, however, a lower priced stock on a per-share basis can attract a wider range of buyers. If that increased demand causes the share price to appreciate, then the total market capitalization rises post-split. This does not always happen, however, often depending on the underlying fundamentals of the business. When a company such as CytRx conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share. Looking at the CYTR split history from start to finish, an original position size of 1000 shares would have turned into 6.90852013971791 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into CytRx shares, starting with a $10,000 purchase of CYTR, presented on a split-history-adjusted basis factoring in the complete CYTR split history. CYTR split adjusted history picture

Growth of $10,000.00
Without Dividends Reinvested

Start date: 12/11/2008
End date: 12/10/2018
Start price/share: $15.54
End price/share: $0.56
Dividends collected/share: $0.00
Total return: -96.40%
Average Annual Total Return: -28.27%
Starting investment: $10,000.00
Ending investment: $360.26
Years: 10.00
Date Ratio
02/06/19961 for 4
05/16/20121 for 7
03/07/200810000 for 8616
11/01/20171 for 6
CYTR is categorized under the Healthcare sector; below are some other companies in the same sector that also have a history of stock splits:

CYTX Split History
DARA Split History
DCTH Split History
DFFN Split History
DGX Split History
DHR Split History
DSCI Split History
DSCO Split History
DVA Split History
DVAX Split History

Also explore: CYTR shares outstanding history

Tonix Pharmaceuticals Holding Corp. (TNXP)
SPI Energy Co., Ltd. (SPI)
Spirit Realty Capital, Inc. (SRC)
ReShape Lifesciences Inc. (RSLS)
Churchill Downs Incorporated (CHDN)
Rollins, Inc. (ROL)
Globus Maritime Limited (GLBS)
Regulus Therapeutics Inc. (RGLS)
Neonode Inc. (NEON)
Onconova Therapeutics, Inc. (ONTX)
More latest stock splits »
Latest mega mergers »
Latest stock buybacks »

CYTR Insider Buying

CYTR Split History | www.SplitHistory.com | Copyright © 2013 - 2018, All Rights Reserved

Nothing in www.SplitHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.